Trials / Sponsors / ONL Therapeutics
ONL Therapeutics
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD) | Phase 2 | 2025-10-28 |
| Completed | A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Rhegmatogenous Retinal Detachment - Macula Off | Phase 2 | 2023-04-04 |
| Completed | A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma Open Angle Glaucoma | Phase 1 | 2022-05-02 |
| Completed | ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degenerati Geographic Atrophy | Phase 1 | 2021-07-08 |
| Completed | A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Rhegmatogenous Retinal Detachment - Macula Off | Phase 1 | 2019-10-21 |